Tradestie Institutional Equity Comparison Engine
NMR vs HLI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NMR Overall Edge
NMR Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nomura Holdings, Inc (NMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMR trades at 12.7x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus HLI at 16.6x Forward P/E and 22.8% operating margin (+4.8% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against HLI sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
NMR
NMR 12.7x vs HLI 16.6x Fwd P/E
Growth & Margin Winner
NMR
Op Margin 25.1% vs 22.8% ยท YoY +17.9% vs +4.8%
Momentum & Technical Winner
NMR
1Y +26.3% vs -23.3% ยท 52W Pos 60% vs 31%
Options & Structure Winner
NMR
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (2nd %ile IV)
NMR
NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap
$28.3B
1M Return
+2.36%
1Y Return
+26.32%
Forward P/E
12.7x
Unified AI Score
44.5 / 100
HOLD
Tech 47.0
Fund 49.0
Flow 50.0
Mom 50.0
HLI
NYSE
Houlihan Lokey, Inc.
Investment Advice
$138.11
-2.31% 1D
Market Cap
$9.9B
1M Return
+8.69%
1Y Return
-23.27%
Forward P/E
16.6x
Unified AI Score
37.0 / 100
SELL
Tech 20.0
Fund 44.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMR +26.32%
HLI -23.27%
Spread: +49.59 pp (NMR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NMR TTM Op. Margin: 25.1%
HLI TTM Op. Margin: 22.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs HLI. Trailing 12-month operating profitability (NMR 25.1% vs HLI 22.8%) and valuation multiples (NMR 12.7x vs HLI 16.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMR | HLI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $28.3B | $9.9B | Larger Scale | NMR |
| Trailing P/E Ratio Valuation | 11.2x | 24.0x | Lower Multiple | NMR |
| Forward P/E Ratio Valuation | 12.7x | 16.6x | Lower Multiple | NMR |
| Revenue Growth (YoY) Growth | +17.9% | +4.8% | Higher Growth | NMR |
| Operating Margin (TTM) Profitability | 25.1% | 22.8% | Higher Margin | NMR |
| Net Profit Margin Profitability | 17.1% | 15.8% | Higher Margin | NMR |
| Return on Equity (ROE) Capital Efficiency | 11.5% | 17.3% | Higher ROE | HLI |
| 52-Week Range Position Momentum | 60% ($7โ$11) | 31% ($113โ$195) | Stronger Trend | NMR |
| Beta / 30D Volatility Risk Regime | 1.03ฮฒ ยท 29% Vol | 0.71ฮฒ ยท 40% Vol | Lower Realized Risk | NMR |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 37.0 / 100 (SELL) | Higher Composite | NMR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMR vs HLI Buy Guide
NMR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
HLI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMR nor HLI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.